Theodore V. Wells, Jr.
Recognized in:Bet-the-Company LitigationCommercial Litigation...
Law School:Harvard Law School
Location:1285 Avenue of the AmericasNew York, NY 10019-6064
- Harvard Business School, MBA, graduated 1976
- Harvard Law School, J.D., graduated 1976
- College of the Holy Cross, BA, graduated 1972
- District of Columbia, District of Columbia
- New York, State of New York
- New Jersey, State of New Jersey
Named "Lawyer of the Year" by Best Lawyers for:
- Bet-the-Company Litigation, New York City (2013)
- Criminal Defense: White-Collar, New York City (2010)
Recognized in The Best Lawyers in America for work in:
- Bet-the-Company Litigation
- Commercial Litigation
- Criminal Defense: White-Collar
- Litigation - Environmental
- Litigation - Regulatory Enforcement (SEC, Telecom, Energy)
- Litigation - Securities
Areas of Expertise:
- White-Collar Criminal Defense
In 2010, Ted successfully defended Citigroup in a three-week jury trial where the plaintiff, the London-based private equity firm Terra Firma, claimed it was defrauded in connection with its purchase of the music company EMI, and claimed over $8 billion in damages.
In 2008, Ted successfully defended Citigroup in a five-month jury trial where the plaintiff alleged that Citigroup aided and abetted in the massive fraud at Parmalat, the Italian dairy and food corporation. The jury totally rejected the $2 billion claim for damages against Citigroup and also awarded Citigroup $364 million on Citigroup's counterclaim.
In 2012, Ted served as lead trial counsel for Bank of America in the massive securities class action relating to Bank of America's acquisition of Merrill Lynch & Co. The case was settled on the eve of trial.
In 2013, Ted served as lead counsel for Merck in the massive securities fraud class action relating to the drug Vytorin. The case was settled on the eve of trial.
Ted was lead trial counsel for Merck in the federal regulatory investigations related to Vioxx and was lead counsel for Abbott Laboratories in the federal regulatory investigations relating to Depakote. Both the Vioxx and Depakote federal regulatory investigations were successfully settled in 2012.
Toronto-Dominion Centre, Suite 3100
77 King Street West
P.O. Box 226
Toronto, ON M5K 1J3
Unit 3601, Fortune Plaza Office Tower A
No. Seven Dongsanhuan Zhonglu
86 10 5828 6300
Hong Kong Club Building, 12th Floor
3-A Chater Road, Central
852 2846 0300
Fukoku Seimei Building 2F
2-2, Uchisaiwaicho 2-chome
81 3 3597 8101
10 Noble Street
London EC2V 7JU
44 20 7367 1600
500 Delaware Avenue, Suite 200
P.O. Box 32
Wilmington, DE 19899-0032
District of Columbia
District of Columbia
2001 K Street, NW
Washington, DC 20006-1047